18.12.2012 Views

Myeloid Leukemia

Myeloid Leukemia

Myeloid Leukemia

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Diagnosis of CBFB-MYH11-Positive AML 169<br />

2. The control PCR (e.g., RAR) of all samples is positive.<br />

3. The sensitivity is more than 1 in 100.<br />

4. All negative controls are negative.<br />

5. Both duplicate analyses are positive; i.e., a clear CBFB-MYH11 PCR product is<br />

visible after UV exposure of the agarose gel.<br />

6. The specificity of the CBFB-MYH11 PCR product has been confirmed by<br />

sequencing.<br />

A sample is considered to be negative when:<br />

1. The quality of the RNA is good as determined by agarose gel electrophoresis (see<br />

Note 6).<br />

2. The control PCR (e.g., RAR PCR) of all samples is positive.<br />

3. The sensitivity is more than 1 in 100.<br />

4. All negative controls are negative.<br />

5. Both duplicate analyses are negative.<br />

3.2. Diagnosis of CBFB-MYH11-Positive AML by Quantitative MYH11<br />

RT-PCR<br />

Real-time quantitative PCR (qPCR) is currently being used for routine identification<br />

and quantification of fusion genes and transcripts associated with<br />

hematological malignancies. The value for an individual sample as obtained<br />

with real-time PCR is represented by the cycle at which a signal is detected<br />

above the background. This value is called the threshold cycle (Ct) value. When<br />

applying a calibrator series with known amounts of input (e.g., diluted cells or<br />

molecules yielding a calibration curve with Ct values) the amount of a given<br />

sample can be calculated. Naturally, individual values should be corrected for<br />

variations in PCR efficiency, cDNA input, and so on, using a reference gene.<br />

3.2.1 Quantitative MYH11 PCR to Identify CBFB-MYH11-Positive Cases<br />

Among Newly Diagnosed AML<br />

The amplicon size used in qPCR should be less than 300 bp to guarantee<br />

efficient amplification. Because the distance between the smallest and longest<br />

CBFB-MYH11 fusion transcript is over 1200 bp, the efficient detection of all<br />

fusion transcripts requires at least four different qPCRs. The MYH11 gene is<br />

very weakly expressed in normal bone marrow cells and CBFB-MYH11-negative<br />

leukemia cells. However, as a result of the fusion to CBFB, the involved<br />

MYH11 moiety is strongly expressed (approx 100- to 1000-fold higher) (13). A<br />

single MYH11 real-time PCR can be applied to function as an initial screen to<br />

identify CBFB-MYH11-positive cases based upon the relatively high MYH11<br />

expression at diagnosis. To completely rule out false-positive results, the presence<br />

of CBFB-MYH11 should subsequently be confirmed with qualitative PCR<br />

as described under Subheading 3.1.1. The MYH11 qPCR is not suitable to

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!